Pharmaceuticals
Mis-selling of drugs to cost J&J $2.2 bn in US settlement
05 Nov 2013
The cases, which date from the late 1990s through the early 2000s, involve alleged kickbacks to doctors and pharmacies to promote the antipsychotic drugs Risperdal and Invega, and heart drug Natrecor
.webp)
.webp)
